The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| VREX | -7.54% | -18.7% | -4.06% | -57% |
| S&P | +15.06% | +95.03% | +14.29% | +195% |
Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. It operates through the Medical and Industrial segments. The Medical segment delivers and services x-ray imaging components, including X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, and three-dimensional reconstruction software. The Industrial segment offers x-ray imaging products for use in security, and nondestructive testing and inspection applications. The company was founded in July 2016 and is headquartered in Salt Lake City, UT.
The company is recovering from the steep losses it experienced during the height of the COVID-19 pandemic.
Shares swoon after the company announces that it is raising capital.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $203.00M | -2.9% |
| Gross Profit | $67.50M | 0.9% |
| Gross Margin | 33.25% | 1.3% |
| Market Cap | $359.81M | -40.3% |
| Market Cap / Employee | $0.16M | 0.0% |
| Employees | 2.3K | 0.0% |
| Net Income | -$89.10M | -6040.0% |
| EBITDA | $20.00M | 22.7% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $136.40M | -12.8% |
| Accounts Receivable | $137.00M | -9.9% |
| Inventory | 298.7 | 6.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $391.10M | -6.9% |
| Short Term Debt | $5.80M | -88.4% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -11.39% | -14.2% |
| Return On Invested Capital | -0.31% | -1.4% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $0.70M | -74.1% |
| Operating Free Cash Flow | $7.00M | -5.4% |
| Metric | Q4 2023 | Q1 2024 | Q2 2024 | YoY Change | |
|---|---|---|---|---|---|
| Price to Earnings | 22.75 | 21.71 | 21.43 | - | |
| Price to Book | 0.84 | 1.12 | 0.89 | 0.65 | -37.32% |
| Price to Sales | 0.60 | 0.71 | 0.51 | 0.44 | -39.00% |
| Price to Tangible Book Value | 1.77 | 2.63 | 2.00 | 1.47 | -34.19% |
| Price to Free Cash Flow TTM | 26.94 | 24.94 | 11.43 | 10.40 | -31.42% |
| Enterprise Value to EBITDA | 44.45 | 53.87 | 28.29 | 31.18 | -43.60% |
| Free Cash Flow Yield | 3.7% | 4.0% | 8.8% | 9.6% | 45.82% |
| Return on Equity | -8.7% | -8.6% | -7.5% | -25.6% | -515.91% |
| Total Debt | $476.70M | $598.30M | $596.80M | $396.90M | -15.61% |
VREX earnings call for the period ending June 30, 2022.
VREX earnings call for the period ending December 31, 2021.
VREX earnings call for the period ending September 30, 2021.
VREX earnings call for the period ending June 30, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
